case_id,Q0,Q1,Q2,Q3,Q4,Q5,Q6,Q7,Q8,Q9,Q10,Q11,Q12,Q13,Q14,Q15,Q16,Q17,Q4_followup,Q9_followup,Q10_followup,Q4_follow_up,Q9_follow_up,Q10_follow_up
Case2,Whole exome sequencing (WES); gene content includes all protein-coding regions of the genome.,Yes,No,No,No,Yes,No,No,No,No,Yes,Not specified,No,Yes,Not listed,No,No,"To submit the claim, ensure prior authorization is obtained, provide documentation of medical necessity per policy criteria, include clinical notes, prior genetic testing results (such as the negative CMA), and the ordering provider's information. Submit all required forms through the UnitedHealthcare provider portal or as directed by the payer.",,,,,,
Case1,"Whole exome sequencing (WES), which analyzes the coding regions of all known genes to identify potential genetic causes of neurodevelopmental disorders.",Yes,Yes,Yes,Yes,Yes,No,Yes,No,Yes,No,Yes,No,Yes,Not listed,No,Yes,"The genetic counselor or ordering provider must submit a prior authorization request to UnitedHealthcare, including comprehensive clinical documentation: the patient's clinical history, prior negative chromosomal microarray results, family history of neurodevelopmental disorders, and the rationale for whole exome sequencing. Await approval before proceeding with testing. Ensure genetic counseling is documented as provided.",ACMG,Yes,Diagnostic,,,
Case3,BRCA1/BRCA2 genetic testing for hereditary breast and ovarian cancer risk assessment,Yes,Yes,Yes,Yes,Not required,No,Yes,No,Yes,No,Yes,No,Yes,Not listed,No,Yes,"Submit prior authorization request with documentation of the patient's strong family history of breast and ovarian cancer (mother with breast cancer at age 42, maternal aunt with ovarian cancer), the patient's age (35), and confirmation that genetic counseling was provided. Include the recommendation from the genetic counselor and specify that this testing is for risk assessment to guide management decisions.",,,,NCCN,Yes,Risk Assessment
Case4,BRCA1/BRCA2 genetic testing for hereditary breast and ovarian cancer risk assessment,No,No,No,No,Not required,No,No,No,Yes,No,Not specified,No,Yes,Not listed,No,No,"According to the policy, prior authorization is required for BRCA1/BRCA2 testing. The request must include documentation of clinical risk factors that meet the policy criteria. For this patient, since the criteria are not met, the test would not be approved. If the provider still wishes to pursue testing, they would need to document medical necessity with additional risk factors or obtain a referral to a genetics professional who could evaluate the patient according to recognized guidelines.",,,,,No,Risk Assessment
